Terms ending in 2032
Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,783,792 | Purification of Butyrylcholinesterase Using Membrane Adsorption In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,793,855 | Tfpi Inhibitors and Methods of Use In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 9,315,560 | Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,274,122 | Methods for Determining Active Ingredients in Pro-Drug Peg Protein Conjugates with Releasable Peg Reagents (in Vitro De-Pegylation) In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,603,830 | Method for the Determination of Polysorbate 80 In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,852,888 | METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,652,793 | Solid Phase-Bound Elastase-Binding Assay for the Measurement of ALPHA1-ANTITRYPSIN Activity In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,772,240 | Ethanol Dependence of ALPHA1 Antitrypsin C-Terminal Lys Truncation by Basic Carboxypeptidases In force · High confidence | Baxalta GmbH and Baxalta Incorporated | In force | High confidence | |
| US 8,684,433 | Packaging for Multiple Medical Containers In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,488,625 | Purification of Factor VIII Using a Conductivity Gradient In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| 15 more term ends in 2032 · Pro | |||||
10 of 25 patents shown. Soonest term end first, then patent number.
Pro members see all 25.
3 of these are in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.